Immune-checkpoint-inhibitor therapy directed against PD-L1 is tolerated in the heart without manifestation of cardiac inflammation in a preclinical reversible melanoma mouse model

• Caroline Schoenherr
• Stefan Pietzsch
• Cristina Barca
• Franziska E Müller
• Frauke Sophie Bahr
• Martina Kasten
• Andre Zeug
• Sergej Erschow
• (EE) Christine Susanne Falk
• 3 more
• Melanie Ricke-Hoch